Daratumumab and Ofatumumab Data to Be Presented at ASH

[at noodls] – Media Release – Seven Genmab abstracts accepted for presentation at ASH – Additional preliminary safety and efficacy data from daratumumab Phase I/II study Copenhagen, Denmark; November 5, 2012 -Genmab … more

View todays social media effects on GENC

View the latest stocks trending across Twitter. Click to view dashboard